-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ip10dI3Yc95fXm2hAlh2uERJyr3TjnRY6dlpN7Pj7togXI0c1hghU9znhJ75+2fd f77q6n83JeM/LNX8/4idtg== 0000899140-97-000732.txt : 19971111 0000899140-97-000732.hdr.sgml : 19971111 ACCESSION NUMBER: 0000899140-97-000732 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19971110 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TRANSKARYOTIC THERAPIES INC CENTRAL INDEX KEY: 0000885259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043027191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47221 FILM NUMBER: 97711800 BUSINESS ADDRESS: STREET 1: 195 ALBANY ST CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 6173490200 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WARBURG PINCUS CAPITAL CO LP CENTRAL INDEX KEY: 0000898600 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 061183391 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVENUE 10TH FLOOR STREET 2: C/O E M WARBURG PINCUS & CO CITY: NEW YORK STATE: NY ZIP: 10017-3147 BUSINESS PHONE: 2128780600 MAIL ADDRESS: STREET 1: C/O WARBURG PINCUS & CO STREET 2: 466 LEXINGTON AVENUE 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017-3147 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13G ------------------------------- OMB APPROVAL ------------------------------- OMB Number: 3235-0145 Expires: December 31, 1997 Estimated average burden hours per response.....14.90 ------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Transkaryotic Therapies, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 893735-10-0 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 1 - ---------------------- CUSIP No. 893735-10-0 13G - ---------------------- - ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus Capital Company, L.P. - ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - ---------- --------------------------------------------------------------------- 3 SEC USE ONLY - ---------- - ---------- -------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - -------------------- ------ --------------------------------------------------- 5 SOLE VOTING POWER -0- ------ --------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 4,399,745 OWNED BY ------ --------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON -0- WITH ------ --------------------------------------------------- 8 SHARED DISPOSITIVE POWER 4,399,745 - ---------- -------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,399,745 - ---------- -------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 23.5% - ---------- -------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! 2 - --------------------- CUSIP No. 893735-10-0 13G - --------------------- - ---------- -------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON E.M. Warburg, Pincus & Co., LLC - ---------- -------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - ---------- --------------------------------------------------------------------- 3 SEC USE ONLY - ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------- ------ ---------------------------------------------------- 5 SOLE VOTING POWER -0- ------ ---------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 4,399,745 OWNED BY ------ ---------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON -0- WITH ------ ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 4,399,745 - ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,399,745 - ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 23.5% - ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* OO - ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! 3 - --------------------- CUSIP No. 893735-10-0 13G - --------------------- - ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus & Co. - ---------- --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] - ---------- --------------------------------------------------------------------- 3 SEC USE ONLY - ---------- --------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------- ------ ---------------------------------------------------- 5 SOLE VOTING POWER -0- ------ ---------------------------------------------------- NUMBER OF 6 SHARED VOTING POWER SHARES BENEFICIALLY 4,399,745 OWNED BY ------ ---------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING PERSON -0- WITH ------ ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 4,399,745 - ---------- --------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,399,745 - ---------- --------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - ---------- --------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 23.5% - ---------- --------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - ---------- --------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! 4 Item 1(a). Name of Issuer: Transkaryotic Therapies, Inc. (the "Issuer") Item 1(b). Address of Issuer's Principal Executive Offices: 195 Albany Street Cambridge, Massachusetts 02139 Items 2(a) Name of Person Filing; Address of Principal and (b). Business Office: This statement is filed by and on behalf of (a) Warburg, Pincus Capital Company, L.P., a Delaware limited partnership ("WPCC"); (b) E.M. Warburg, Pincus & Co., LLC, a New York limited liability company ("EMW LLC"); and (c) Warburg, Pincus & Co., a New York general partnership ("WP"). The sole general partner of WPCC is WP. EMW LLC manages WPCC. The members of EMW LLC are substantially the same as the partners of WP. Lionel I. Pincus is the managing partner of WP and the managing member of EMW LLC and may be deemed to control both WP and EMW LLC. WP, as the sole general partner of WPCC, has a 20% interest in the profits of WPCC. The business address of each of the foregoing is 466 Lexington Avenue, New York, New York 10017. WPCC, EMW LLC and WP are collectively referred to herein as the "Reporting Entities." Item 2(c). Citizenship: Not Applicable. Item 2(d). Title of Class of Securities: Common Stock, $.01 par value per share (the "Common Stock"). Item 2(e). CUSIP Number: 893735-10-0 Item 3. Not Applicable. 5 Item 4. Ownership: (a) 4,399,745 shares of Common Stock, as of October 31, 19971. (b) 23.5% (c) (i) -0- (ii) 4,399,745 (iii) -0- (iv) 4,399,745 Item 5. Ownership of Five Percent or Less of a Class: Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not Applicable. Item 8. Identification and Classification of Members of the Group: The agreement required by Rule 13d-1(f)(1)(iii) was previously filed with the Schedule 13G being amended hereby dated February 10, 1997. Item 9. Notice of Dissolution of Group: Not Applicable. Item 10. Certification: Not Applicable. 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: November 7, 1997 WARBURG, PINCUS CAPITAL COMPANY, L.P. By: Warburg, Pincus & Co., its General Partner By:/s/ Stephen Distler --------------------------------- Stephen Distler, Partner WARBURG, PINCUS & CO. By:/s/ Stephen Distler ------------------------------ Stephen Distler, Partner E.M. WARBURG, PINCUS & CO., LLC By: /s/ Stephen Distler ------------------------------ Stephen Distler, Member 7 -----END PRIVACY-ENHANCED MESSAGE-----